Abstract:Background: Progression of Alzheimer's disease leads to synapse loss, neural network dysfunction and cognitive failure. Accumulation of protein aggregates and brain immune activation have triggering roles in synaptic failure but the neuronal mechanisms underlying synapse loss are unclear. On the neuronal surface, cellular prion protein (PrPC) is known to be a high-affinity binding site for Amyloid-β oligomers (Aβo). However, PrPC's dependence in knock-in AD models for tau accumulation, transcriptomic alterations and imaging biomarkers is unknown. Methods: The necessity of PrPC was examined as a function of age in homozygous AppNL-G-F/hMapt double knock-in mice (DKI). Phenotypes of AppNL-G-F/hMapt mice with a deletion of Prnp expression (DKI; Prnp-/-) were compared with DKI mice with intact Prnp, mice with a targeted deletion of Prnp (Prnp-/-), and mice with intact Prnp (WT). Phenotypes examined included behavioral deficits, synapse loss by PET imaging, synapse loss by immunohistology, tau pathology, gliosis, inflammatory markers, and snRNA-seq transcriptomic profiling. Results: By 9 months age, DKI mice showed learning and memory impairment, but DKI; Prnp-/- and Prnp-/- groups were indistinguishable from WT. Synapse loss in DKI brain, measured by [18F]SynVesT-1 SV2A PET or anti-SV2A immunohistology, was prevented by Prnp deletion. Accumulation of Tau phosphorylated at aa 217 and 202/205, C1q tagging of synapses, and dystrophic neurites were all increased in DKI mice but each decreased to WT levels with Prnp deletion. In contrast, astrogliosis, microgliosis and Aβ levels were unchanged between DKI and DKI; Prnp-/- groups. Single-nuclei transcriptomics revealed differential expression in neurons and glia of DKI mice relative to WT. For DKI; Prnp-/- mice, the majority of neuronal genes differentially expressed in DKI mice were no longer significantly altered relative to WT, but most glial DKI-dependent gene expression changes persisted. The DKI-dependent neuronal genes corrected by Prnp deletion associated bioinformatically with synaptic function. Additional genes were uniquely altered only in the Prnp-/- or the DKI; Prnp-/- groups. Conclusions: Thus, PrPC-dependent synapse loss, phospho-tau accumulation and neuronal gene expression in AD mice can be reversed without clearing Aβ plaque or preventing gliotic reaction. This supports targeting the Aβo-PrPC interaction to prevent Aβo-neurotoxicity and pathologic tau accumulation in AD.

Modulation of prion protein expression through cryptic splice site manipulation

Knockdown of the prion gene expression by RNA interference in bovine fibroblast cells

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Divalent siRNA for prion disease

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression

Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor

Antisense oligonucleotides extend survival of prion-infected mice

Knockdown of Prion Protein (prp) by RNA Interference Weakens the Protective Activity of Wild-Type PrP Against Copper Ion and Antagonizes the Cytotoxicity of Fcjd-Associated PrP Mutants in Cultured Cells.

The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis

Biology of the prion gene complex

PrP turnover in vivo and the time to effect of prion disease therapeutics

NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation

Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation

Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders

Targeting neuroinflammation by pharmacologic down-regulation of inflammatory pathways is neuroprotective in protein misfolding disorders

Splice modulators target PMS1 to reduce somatic expansion of the Huntington’s disease-associated CAG repeat

Prions activate a p38 MAPK synaptotoxic signaling pathway

IGF-1-induced Enhancement of PRNP Expression Depends on the Negative Regulation of Transcription Factor FOXO3a.

1-L Transcription in Prion Diseases

The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis

Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein